Linagliptin ameliorated interleukin-29-induced reduction of extracellular matrix genes through the nuclear factor erythroid 2-related factor 2 (Nrf2)/sry-type high-mobility-group box (SOX)-9 axis in an in vitro study on C-28/I2 chondrocytes

References

• Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35.
   PubMed Web of Science ®Google Scholar
• Carr AJ, Robertsson O, Graves S, et al. Knee replacement. Lancet. 2012;379(9823):1331–1340.
   PubMed Web of Science ®Google Scholar
• Glyn-Jones S, Palmer AJ, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376–387.
   PubMed Web of Science ®Google Scholar
• Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010;18(1):24–33.
   PubMed Web of Science ®Google Scholar
• Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17(8):971–979.
   PubMed Web of Science ®Google Scholar
• Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep. 2013;15(11):375.
   PubMed Web of Science ®Google Scholar
• Wang M, Shen J, Jin H, et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci. 2011;1240:61–69.
   PubMed Web of Science ®Google Scholar
• Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol. 2001;12(2):69–78.
   PubMed Web of Science ®Google Scholar
• Pacifici M, Koyama E, Iwamoto M, et al. Development of articular cartilage: what do we know about it and how may it occur? Connect Tissue Res. 2000;41(3):175–184.
   PubMed Web of Science ®Google Scholar
• Tan F, Wang D, Yuan Z. The fibroblast-like synoviocyte derived exosomal long non-coding RNA H19 alleviates osteoarthritis progression through the miR-106b-5p/TIMP2 axis. Inflammation. 2020;43(4):1498–1509.
   PubMed Web of Science ®Google Scholar
• Held A, Glas A, Dietrich L, et al. Targeting beta-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage. Osteoarthritis Cartilage. 2018;26(6):818–823.
   PubMed Web of Science ®Google Scholar
• Geng Q, Zhang H, Cui Y, et al. Febuxostat mitigates IL-18-induced inflammatory response and reduction of extracellular matrix gene. Am J Transl Res. 2021;13(3):979–987.
   PubMed Web of Science ®Google Scholar
• Kong PG, Chen A, Jiang, et al. Sesamin inhibits IL-1-stimulated inflammatory response in human osteoarthritis chondrocytes by activating Nrf2 signaling pathway. Oncotarget. 2016;7:83720–83726.
   PubMedGoogle Scholar
• Cai D, Yin S, Yang J, et al. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. Arthritis Res Ther. 2015;17:269.
   PubMed Web of Science ®Google Scholar
• Davidson RK, Jupp O, de Ferrars R, et al. Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum. 2013;65:3130–3140.
   PubMedGoogle Scholar
• Xu L, Peng Q, Xuan W, et al. Interleukin-29 enhances synovial inflammation and cartilage degradation in osteoarthritis. Mediators Inflamm. 2016;2016:9631510.
   PubMed Web of Science ®Google Scholar
• Jones RB, Vickers SP, Cheetham SC, et al. Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats. Eur J Pharmacol. 2014;729:59–66.
   PubMed Web of Science ®Google Scholar
• Ahren B. DPP-4 inhibition and the path to clinical proof. Front Endocrinol (Lausanne). 2019;10:376.
   PubMed Web of Science ®Google Scholar
• Schernthaner G, Barnett AH, Emser A, et al. Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14(5):470–478.
   PubMed Web of Science ®Google Scholar
• Jo CH, Kim S, Park JS, et al. Anti-Inflammatory action of sitagliptin and linagliptin in doxorubicin nephropathy. Kidney Blood Press Res. 2018;43(3):987–999.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tsuji M, Hasegawa H, et al. Anti-inflammatory effects of linagliptin in hemodialysis patients with diabetes. Hemodial Int. 2014;18(2):433–442.
   PubMed Web of Science ®Google Scholar
• Witte E, Kokolakis G, Witte K, et al. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med (Berl). 2016;94(4):391–400.
   PubMed Web of Science ®Google Scholar
• Deng J, Huang M, Wu H. Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor - like 2 and Sirtuin 2 signaling pathways. Bioengineered. 2021;12(1):7975–7984.
   PubMed Web of Science ®Google Scholar
• Hong Q, Li XD, Xie P, et al. All-trans-retinoic acid suppresses rat embryo hindlimb bud mesenchymal chondrogenesis by modulating HoxD9 expression. Bioengineered. 2021;12(1):3900–3911.
   PubMed Web of Science ®Google Scholar
• Lin TY, Chiu CJ, Kuan CH, et al. IL-29 promoted obesity-induced inflammation and insulin resistance. Cell Mol Immunol. 2020;17(4):369–379.
   PubMed Web of Science ®Google Scholar
• Xu D, Yan S, Wang H, et al. IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis. Cell Physiol Biochem. 2015;37(1):27–34.
   PubMedGoogle Scholar
• Rahmati M, Nalesso G, Mobasheri A, et al. Aging and osteoarthritis: central role of the extracellular matrix. Ageing Res Rev. 2017;40:20–30.
   PubMed Web of Science ®Google Scholar
• Lefebvre V, Huang W, Harley VR, et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997;17(4):2336–2346.
   PubMed Web of Science ®Google Scholar
• Kim KI, Park YS, Im GI. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J Bone Miner Res. 2013;28(5):1050–1060.
   PubMed Web of Science ®Google Scholar
• Zhou B, Chen D, Xu H, et al. Proliferation of rabbit chondrocyte and inhibition of IL-1beta-induced apoptosis through MEK/ERK signaling by statins. Vitro Cell Dev Biol Anim. 2017;53(2):124–131.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247.
   PubMed Web of Science ®Google Scholar
• Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40(13). DOI:10.1128/MCB.00099-20
   Web of Science ®Google Scholar